Our team is led by passionate entrepreneurs, seasoned innovators, and medical professionals with deep scientific expertise. Together, we combine entrepreneurial success with cutting-edge research and healthcare experience to drive meaningful innovation.
Angela De Lauretis
CEO & Co-founder
Angela is a chemical engineer and industrial PhD candidate passionate about fostering innovation in the MedTech industry. With hands-on experience in biomaterials characterization and medical device development, she plays a key role in the technical transfer of cutting-edge products to the market. As a Quality Specialist at Corticalis AS, she brings a strong scientific and regulatory understanding, specializing in quality management systems and regulatory affairs to ensure the highest standards of safety and compliance.
Dr. Øystein Øvrebø
CTO & Co-founder
Øystein developed the core technology during his industrial PhD and has spent the past eight years advancing solutions for regenerative therapies. During his PhD, he founded his first company, NuPep AS, which was later acquired by Corticalis AS. He brings experience as an R&D Engineer at the Swiss MedTech company Industrie Biomediche Insubri SA and has also worked in management consulting at Boston Consulting Group.
Prof. Dr. Håvard J. Haugen
CRO & Co-founder
Håvard is a leading researcher in biomaterials with over 20 years of experience and serves as the Head of the Department of Biomaterials at the University of Oslo. Beyond academia, he has played a key role in translating research into industry, contributing to ventures such as Corticalis AS and NuPep AS. At Regenarti, he leads the scientific efforts to validate the quality and performance of our technology.
Prof. Dr. Ståle Petter Lyngstadaas, DDS
CMO & Co-founder
Petter is a leading expert in biomolecules for regenerative medicine with decades of experience in the field. In the 1990s, he served as Head of R&D at Biora AB, where he played a key role in developing Emdogain, now marketed by Swiss Straumann AG. As the CEO of Corticalis AS, he has spearheaded the development of multiple clinically used products. Petter is also the original inventor of our peptide technology, bringing deep scientific expertise and a track record of innovation to the team.
Regenarti AS 